Chlamydia infection: topical issues

1. Рубаник Л.В., Шиманович В.П., Глинская И.Н., Зданович Н.Н., Полещук Н.Н. Анализ заболеваемости урогенитальной хламидийной инфекцией в Республике Беларусь за период 2001-2015 гг. Лабораторная диагностика. Восточная Европа. 2017; 2(6): 257-265. [Rubanik L.V., Shimanovich V.P., Zdanovich N.N., Poleshchuk N.N. Analysis of the incidence of urogenital chlamydia infection in Belarus for the period. Laboratori diagnostics. Eastern Europe. 2001-2015 years. 2017; 2(6): 257-265. (in Belarus)]
2. Кубанова А.А., Кубанов А.А., Мелехина Л.Е. Динамика изменений интенсивных показателей заболеваемости инфекций, передаваемых половым путем, в оценке эпидемиологического процесса и состояния здоровья населения Российской Федерации за 2006–2016 годы. Вестник дерматологии и венерологии. 2018; 91(1): 27-37. [Kubanova A.A., Kubanov A.A., Melekhina L.E. Dynamics of incidence of sexually transmitted infections in the evaluation of the epidemiological process and state of health of the Russian Federation population in 2006–2016.Vestnik Dermatologiii Venerologii. 2018; 91(1): 27-37. doi.org/10.25208/0042-4609-2018-94-1-27-37.
3. Gotz H.M., van Aar F., van den Broek I.V.F., van Bergen J.E.A.M., Donker G.A., Hek K. et al. Synthesis of results of pick-up: potential of expedited partner therapy for Chlamydia in the Netherlands: Proceedings of the Fourteenth international symposium on human chlamydial infections. 2018, July 1-6; Zeist; The Netherlands. The Netherlands; 2018:77-81.
4. Filardo S., Marisa D. P., Porpora M. G., Recine N., Farcomeni A., Latino M.A. et al. Diversity of Cervical Microbiota in Asymptomatic Chlamydia trachomatis Genital Infection: A Pilot Study. Front. Cell. Infect. Microbiol. 2017; 7: 321. doi: 10.3389/fcimb.2017.00321.
5. Pal. S., Tifrea D.F., de la Maza L.M. Implementation of a new murine model for the characterization of the horizontal and vertical transmission of genital chlamydial infections: Proceedings of the Fourteenth international symposium on human chlamydial infections. 2018, July 1-6; Zeist; The Netherlands. The Netherlands; 2018: 211-215.
6. Versteeg B., Bruisten S.M., Pannekoek Y., Jolley K.A., Maiden M.C.J., van der Ende A. et al. Genomic analysis of the Chlamydia trachomatis core genome shows an association between chromosomal genome, plasmide type and disease: Proceedings of the Fourteenth international symposium on human chlamydial infections. 2018, July 1-6; Zeist; The Netherlands. The Netherlands; 2018: 589-593.
7. Dewart C.M., Bernstein K.T., De Groote N.P., Romaguera R., Turner A.N. Prevalence of rectal chlamydial and gonococcal infections: a systematic review. Sex. Trans. Dis. 2018; 45:280-293. doi: 10.1097/OLQ.0000000000000754.
8. Leenen. J., van Liere G.A.F.S., Hoebe C.J.P.A., Hogewoning A.A., de Vries H.J.C., Dukers-Muijrers N.H.T.M. Preceding oropharyngeal Chlamydia trachomatis infection is not a risk factor for anorectal Chlamydia trachomatis infection in men who have sex with men (MSM) and women: Proceedings of the Fourteenth international symposium on human chlamydial infections. 2018, July 1-6; Zeist; The Netherlands. The Netherlands; 2018: 89-93.
9. Dukers-Muijrers N.H., Schachter J., van Liere G.A.F.S., Wolffs P.F.G., Hoebe C.J.P.A. What is needed to guide testing for anorectal and pharyngeal Chlamydia trachomatis and Neisseria gonorrhoeae in women and men? Evidence and opinion. BMC infectious diseases. 2015; 15:533. doi 10.1186/s12879-015-1280-6.
10. Barbeyrac B., Baita D., Touati A., Bebear C., Peuchant O. Does Chlamydia trachomatis anal infection occur with vaginal infection in women?: Proceedings of the Fourteenth international symposium on human chlamydial infections. 2018, July 1-6; Zeist; The Netherlands. The Netherlands; 2018: 95-97.
11. Rank R., Yeruva L. Hidden in plain sight: chlamydial gastrointestinal infection and its relevance to persistence in human genital infection. Infection and immunity. 2014; 82(4): 1362-1371. doi: 10.1128/IAI.01244-13.
12. Moncada J., Schachter J. In vitro survival of Chlamydia trachomatis in a low pH environment: Proceedings of the Fourteenth international symposium on human chlamydial infections. 2018, July 1-6; Zeist; The Netherlands. The Netherlands; 2018: 131-133.
13. Bavoil P., Marques P. X., Brotman R., Ravel J. Does active oral sex contribute to female infertility. The Journal of infectious disease. 2017; 216(8): 932-5. doi:10.1093/infdis/jix419.
14. Workowski K.A., Bolan G.A. Sexually Transmitted Diseases Treatment Guidelines 2015. MMWR Recomm. Rep. 2015; 64(33):1-137. PMCID: PMC5885289.
15. van Liere G.A.F.S., Dukers-Muijrers N.H.T.M., Hoebe C.J.P.A. Oropharyngeal Chlamydia trachomatis testing and positivity at an STI clinic in the past 5 years; testing more and finding even more: Proceedings of the Fourteenth international symposium on human chlamydial infections. 2018, July 1-6; Zeist; The Netherlands. The Netherlands; 2018: 173-177.
16. van Rooijen M. S., van der Loeff M.F.S, Morré S.A, van Dam A.P., Speksnijder A.G.C.L., de Vries H.J.C. Spontaneous pharyngeal Chlamydia trachomatis RNA clearance. A cross-sectional study followed by a cohort study of untreated STI clinic patients in Amsterdam, The Netherlands. Sex. Transm. Infect. 2015, 91(3): 157-164. doi: 10.1136/sextrans-2014-051633.
17. Menon S., Timms P., Allan J.A., Alexander K., Rombauts L., Horner P. et al. Human and pathogen factors associated with Chlamydia trachomatis-related infertility in women. Clin. Microbiol. Rev. 2015; 28(4): 969-85.doi: 10.1128/CMR.00035-15.
18. Quigley B.L., Hanger J., Carver S., Timms P. Moddeling analysis of urogenital and ocular chlamydial disease reveals distinct host and chlamydial factors lead to clinical disease, using the koala as a model system: Proceedings of the Fourteenth international symposium on human chlamydial infections. 2018, July 1-6; Zeist; The Netherlands. The Netherlands; 2018: 61- 64.
19. Toh E., Gao X., Lin H., Dong Q., Batteiger T., Jordan S.J. et al. C trachomatis infection profoundly alters the urethral microbiome in men: Proceedings of the Fourteenth international symposium on human chlamydial infections. 2018, July 1-6; Zeist; The Netherlands. The Netherlands; 2018:509-512.
20. Taylor S.N., Lensing S., Schwebke J., Lillis R., Mena L.A., Nelson A.L et al. Prevalence and treatment outcome of cervicitis of unknown etiology. Sex. Trans. Dis.2013;40(5): 379-85. PMID:23588127.doi: 10.1097/OLQ.0b013e31828bfcb1.
21. Prusty B.K., Siegl C., Hauck P., Hain J., Korhonen S.J., Hitunen-Back E. et al. Chlamydia trachomatis infection induces replication of latent HHV-6. PLos One 2013; 8(4):e61400. doi:10.1371/journal.pone.0061400.
22. Hafner L. Pathogenesis of fallopian tube damage caused by Chlamydia trachomatis infections. Contraception. 2015; 92:108-115. doi: 10.1016/j.contraception.2015.01.004.
23. Zou X., Liu T., Gong Z., Hu C., Zhang Z. Micro RNAs-mediated epithelial-mesenchymal transition in fibrotic diseases. Eur. J. Pharmacol. 2017; 796: 190-206. doi: 10.1016/j.ejphar.2016.12.003.
24. Helble J. D., Roan N.R., Starnbach M.N. Immune components required for control of Chlamydia infection: Proceedings of the Fourteenth international symposium on human chlamydial infections. 2018, July 1-6; Zeist; The Netherlands. The Netherlands; 2018: 431-440.
25. Morre S.A., Karimi O., Ouburg S. Chlamydia trachomatis: identification of susceptibility markers for ocular and sexually transmitted infection by immunogenetics. FEMS Immunol. Med. Microbiol. 2009; 55(2): 140-53.doi: 10.1111/j.1574-695X.2009.00536.
26. Hoenderboom B.M., Jukema J.B., van Benthem B.H., van den Broek I.V., van der Sande M.A., de Vries H.J.C. et al. The role of SNPs in the TRL2, NOD1, CXCR5, and IL10 genes in the course of Chlamydia trachomatis infections: Proceedings of the Fourteenth international symposium on human chlamydial infections. 2018, July 1-6; Zeist; The Netherlands. The Netherlands; 2018:605-609.
27. Verweij S.P., Karimi O., Pleijster J., Lyons M.J., de Vries H.J.C., Land J.A. et al. TLR2, TLR4 and TLR9 genotypes and haplotypes in the susceptibility to and clinical course of Chlamydia trachomatis infections in Dutch women. Pathog. Dis. 2016; 74(1): ftv107. doi: 10.1093/femspd/ftv107.
28. Brankovic I., van Ess E.F., Noz M.P., Wiericx J. W., Spaargaren J., Morre S.A. et al. NOD1 in contrast to NOD2 functional polymorphism influence Chlamydia trachomatis infection and the risk of tubal factor infertility. Pathog. Dis. 2015; 73(1): 1-9. doi: 10.1093/femspd/ftu028.
29. Jiang J., Karimi O., Ouburg S., Champion C.I., Khurana A., Liu G. Interruption of CXCL13-CXCR5 axis increases upper genital tract pathology and activation of NK Tcells following chlamydial genital infection. PLo S One. 2012; 7(11): e47487. doi: 10.1371/journal.pone.0047487.
30. Ohman H., Tiitinen A., Halttunen M., Lehtinen M., Paavonen J., SurcelH.-M. Cytokine polymorphism sandseverity of tubal damage in women with Chlamydia-associated infertility. J. Infect. Dis. 2009; 199(9): 1353-9.doi: 10.1086/597620.
31. Hoenderboom B. M., Jukema J.B., van Benthem B.H., van den Broek I.V., van der Sande M.A., de Vries H.J.C et al. The role of SNPs in the TRL2, NOD1, CXCR5, and IL10 genes in the course of Chlamydia trachomatis infections: Proceedings of the Fourteenth international symposium on human chlamydial infections. 2018, July 1-6; Zeist; The Netherlands. The Netherlands; 2018:605-609.
32. Schachter J. Diagnosis of Chlamydia trachomatis infection with some comments on other Chlamydiae: Proceedings of the Fourteenth international symposium on human chlamydial infections. 2018, July 1-6; Zeist; The Netherlands. The Netherlands; 2018: 333-340.
33. Федеральные клинические рекомендации. Дерматовенерология 2015: Болезни кожи. Инфекции, передаваемые половымпутем. М.: Деловой экспресс. 2016; 768с. [Federal clinical guidelines. Dermatovenereology 2015: Diseases of the skin. Sexually Transmitted Infections. Мoscow: Business Express. 2016; 768р. (in Russian)]
34. Ripa T., Nilsson P. A variant of Chlamydia trachomatis with deletion in cryptic plasmid: implications for use of PCR diagnostic tests. Euro Surveill. 2006; 11(11): E061109.2.
35. Федорова В. А., Коннова С. С., Полянина Т. И., Дружкин И.Н., Федотов Э.А., Мотин В.Л. Использование различных мишеней для выявления штаммов Chlamydia trachomatis. Известия Саратовского университета. Новая серия. Серия. Химия. Биология. Экология. 2011; 11(2): 73-77. [Feodorova V.A., Konnova S.S., Polyanina T.I., Druzhkin I.N., Fedotov E.A., Motin V.L. Use of different target for detection of Chlamydia trachomatis. Journal Izvestiya of Saratov University. New Series. Series: Chemistry. Biology. Ecology is a scientific periodical. 2011; 11(2): 73-77.(in Russian)]
36. Shipitsyna E., Hadad R., Ryzhkova O., Savicheva A., Domeika M., Unemo M. First reported case of the Swedish new variant of Chlamydia trachomatis (nvCT) in Eastern Europe (Russia), and evaluation of Russian nucleic acid amplification tests regarding their ability to detect nvCT. Acta DermatoVenereologica. 2012; 92(3): 330–331. doi:10.2340/00015555-1269
37. Рубаник Л.В., Капустина Ю.М., Асташонок А.Н., Полещук Н.Н. Медицинские новости. 2017; 12: 49–53. [Rubanik L.V., Kapustina Y.M., Astashonok A.N., Poleshchuk N.N. Detection of mutant “swedish” and plasmid-free variants of Chlamydia trachomatis isolated from persons with urogenitial chlamydiosis in the Republic of Belarus. Medical news. 2017; 12: 49–53 (in Belarus)]
38. Gaydos C.A., Barnes M., Holden J., Silver B., Smith R., Hardick J. et al. Acceptability of a “selfie” or self-collected vaginal swab specimen for enhancing Chlamydia screening in a pharmacy: Proceedings of the Fourteenth international symposium on human chlamydial infections. 2018, July 1-6; Zeist; The Netherlands. The Netherlands; 2018: 353-356.
39. Vodstrcil L.A., Rupasinghe T.W.T., Kong, F. Y. S., Tull D., Worthington K., Chen M.Y., Huston W.M., et al. Measurement of tissue azithromycin levels in selfcollected vaginal swabs post treatment using liquid chromatography and tandem mass spectrometry. PLoS One. 2017; 12(5): e0177615. https://doi.org/10.1371/journal.pone.0177615.
40. Savaris R.F, Fuhrich D.G, Duarte R.V, Franik S, Ross J. Antibiotic therapy for pelvic inflammatory disease (Review). Cochrane Database of Systematic Reviews 2017; Issue 4. Art. No.: CD010285. doi: 10.1002/14651858.CD010285.pub2.
41. Unemo M., Endre K.M., Moi H. Five-day Azithromycin treatment regimen for Mycoplasma genitalium infection also effectively eradicates Chlamydia trachomatis. Acta DermatoVenereologica. 2015; 95(6): 730-732.doi:10.2340/00015555-2108.
42. Асхаков М.С., Чеботарев В.В., Вышеславцев В.В. Диагностика и лечение инфекций, передаваемых половым путем, «второй генерации». Медицинский вестник Северного Кавказа. 2014; 9(1): 102-107. [Askhakov M.C., Chebotarev V.V., Vysheslavtsev V.V. Diagnosis and treatment of sexually transmitted infections of the second generation. Medical news of the North Caucasus. 2014; 9(1): 102-107. (in Russian)]
43. Jensen J.S., Bradshaw C. Management of Mycoplasma genitalium infections – can we hit a moving target? BMC Infect Dis. 2015; 15:343. doi:10.1186/s12879-015-1041-6.
44. Horner P., Saunders J. Should azithromycin 1 g be abandoned as a treatment for bacterial STIs? The case for and against. The Case for and Against. Sex Transm Infect. 2017; 93(2): 85-87. doi:10.1136/sextrans-2015-052414.
45. Khosropour C.M., Bell T.R., Hughes J.P., Manhart L.E., Golden M.R. A population-based study to compare treatment outcomes among women with urogenital chlamydial infection in Washington State, 1992-2015. Sex. Trans. Dis. 2018; 45: 319-324. doi: 10.1097/OLQ.0000000000000764.
46. Malogajski J., Brankovic I., Land J.A., Morré S.A., Ambrosino E. Potential of Chlamydia trachomatis host genetic profiling to modify the screening for tubal factor infertility (TFI) – the Dutch perspective: Proceedings of the Fourteenth international symposium on human chlamydial infections. 2018, July 1-6; Zeist; The Netherlands. The Netherlands;2018: 223-226.
47. Geisler W., Lensing S.Y., Press C.G, Hook E.W. Spontaneous resolution of genital Chlamydia trachomatis infection in women and protection from reinfection. J. Infect. Dis. 2013. 207: 1850-6. doi: 10.1093/infdis/jit094.

Received 17.09.2018

Accepted 21.09.2018